• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Silo Pharma Inc (OP: SILO )

N/A UNCHANGED
Last Price Updated: 3:23 PM EDT, Sep 14, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Silo Pharma Inc

< Previous 1 2 3 4 Next >
Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study
July 25, 2022
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO), UMB Collaborating on Potentially Significant Homing-Peptide Technology
July 22, 2022
Via Investor Brand Network
Study Says Ayahuasca Users Tend to Exercise More, Eat Healthier
July 21, 2022
Via Investor Brand Network
Topics Religion
Exposures Religion
Study Finds That Microdosing Psilocybin Mushrooms Improves Mood, Mental Health
July 15, 2022
Via Investor Brand Network
Homing Peptides: Silo Pharma Inc. (SILO) Targets ADRs
July 13, 2022
Via Investor Brand Network
Silo Pharma Inc. (SILO) Takes Aim at Alzheimer’s Disease
June 27, 2022
Via Investor Brand Network
Study Suggests COVID-19 Increases Parkinson’s Disease Risk
May 27, 2022
Via Investor Brand Network
Exposures COVID-19
New Research Suggests Mental Disorders Magnify Dementia Risk
May 23, 2022
Via Investor Brand Network
Study Maps How Brain Changes During Treatment for Depression
July 14, 2022
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Announces Positive Results of New Study
July 12, 2022
Via Investor Brand Network
DEA Sets Hearing Date Regarding Plan to Ban Several Psychedelics
July 12, 2022
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Bringing Hope, Possible Therapeutic to Alzheimer’s Patients
July 08, 2022
Via Investor Brand Network
Federal Health Agencies Admit That Classification of Psychedelics Is Impeding Research
July 07, 2022
Via Investor Brand Network
Brain Cell Regulation Mechanism Could Unlock Novel Treatment Modalities for Neurological Conditions
July 06, 2022
Via Investor Brand Network
New Report Says Smoking Amplifies Schizophrenia and Depression Risk
June 28, 2022
Via Investor Brand Network
What Investors Interested in Psychedelics Need to Focus on Regarding IP Issues
June 27, 2022
Via Investor Brand Network
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Announces Expansion of License Agreement and Patent Portfolio
June 23, 2022
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Study Finds Frequent Nightmares May Be Sign of Parkinson’s Disease Development
June 22, 2022
Via Investor Brand Network
New Study Finds Dose Tapering May Heighten Risk of Opioid Overdoses
June 21, 2022
Via Investor Brand Network
Mystical Experiences Due to Psilocybin Linked to Positive Mental Well-Being
June 16, 2022
Via Investor Brand Network
Study Says Damage to Neurons, Not Plaque Triggers Alzheimer’s Onset
June 14, 2022
Via Investor Brand Network
Topics Death
Exposures Death
Five Books on Psychedelics You May Enjoy Reading
June 13, 2022
Via Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Committed to Psilocybin, Anti-Inflammatory Research
June 13, 2022
Via Investor Brand Network
Study Offers New Insights into Psilocybin’s Mechanism for Treating Depression
June 08, 2022
Via Investor Brand Network
At least 4 in 10 Long-COVID Patients Report Symptoms Akin to Fibromyalgia
June 07, 2022
Via Investor Brand Network
Exposures COVID-19
UK Firm Develops Inhaler to Facilitate Psychedelic Microdosing
June 03, 2022
Via Investor Brand Network
UC Davis Awarded Grant to Find New Non-hallucinogenic Psychedelic Treatments for Addiction
May 31, 2022
Via Investor Brand Network
Silo Pharma Inc. (SILO) Focuses on Psilocybin’s Anti-Inflammatory Properties
May 31, 2022
Via Investor Brand Network
Davos Hosts Psychedelic Medical Series
May 25, 2022
Via Investor Brand Network
Exposures COVID-19
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Bringing Hope to Patients Suffering from Alzheimer’s and Potentially Other Ailments
May 23, 2022
Via Investor Brand Network
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap